About us
GreenBull Medical Division is a registered trademark owned by Peristegraf srl
VAT IT01768221002
Via G. Peroni, 130
Rome (Italy) – 00131
€33,00
The COVID-19 Antigen Rapid Test is a lateral flow immunoassay intended for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in the nasopharyngeal swab and oropharyngeal swab of individuals suspected of having COVID-19. The rapid test for COVID-19 antigen is intended for use by specifically trained clinical laboratory personnel instructed and trained in in vitro diagnostic procedures.
The COVID-19 Antigen Rapid Test Cassette is designed to detect nucleocapsid antigen from SARS-CoV-2 in nasopharyngeal swab and oropharyngeal swab of patients with suspected COVID-19.